Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJessica El‐AsmarDNDaniel Paul NurseZTZhengkai Tu

Discussion

Loading...

Member takes

Overview

Retrospective cohort study finds distinct prognostic correlates of mutations in Polycomb Repressive Complex in Acute Myeloid Leukemia patients.

Key Points

  • Patients with Acute Myeloid Leukemia exhibit distinct clinical features based on Polycomb Repressive Complex mutations.
  • The study found a similar complete response rate between mutated and wildtype ASXL1 and BCOR AML cases.
  • Analysis included a retrospective cohort using Kaplan-Meier and Cox regression methods to evaluate treatment outcomes.
  • Polycomb Repressive Complex mutations may influence treatment responses, indicating the need for further research.

Cite This Study

El‐Asmar et al. (2025) studied this question.

synapsesocial.com/papers/69362f744fa91c937236e295https://doi.org/10.1182/blood-2025-7035
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic relevance of mutational profile in secondary Acute Myeloid Leukemia patients treated with CPX-351.2025
  2. 2Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort2025
  3. 3Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort2025 · 1 citations
  4. 4Prognostic impact of ASXL1 somatic mutation on patients with chronic myeloid leukemia: A systemic review and meta-analysis.2026
  5. 5Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia2025